Medford, MA, United States of America

Sriram Krishnamoorthy

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Innovator Sriram Krishnamoorthy: Pioneering Advances in Factor VIII Therapy

Introduction

Sriram Krishnamoorthy, based in Medford, MA, is an accomplished inventor recognized for his contributions to medical innovations, particularly in hematology. With two patents to his name, his research significantly impacts the treatment of individuals undergoing factor VIII therapy.

Latest Patents

Krishnamoorthy's latest patents focus on methods aimed at reducing immunogenicity against factor VIII. These innovations involve administering chimeric and hybrid Factor VIII (FVIII) polypeptides that comprise FVIII and Fc. The methods are designed for subjects at risk of developing inhibitory FVIII immune responses, including anti-FVIII antibodies and cell-mediated immunity. The administration of these polypeptides aims to promote coagulation and induce immune tolerance to FVIII, incorporating full-length FVIII or variants with deletions of the B domain.

Career Highlights

Throughout his career, Sriram Krishnamoorthy has made notable strides in the biomedical field. He has held key positions at reputable organizations such as Bioverativ Therapeutics Inc. and the Puget Sound Blood Center. His work at these institutions has contributed to significant advancements in the understanding and treatment of blood disorders.

Collaborations

Collaborating with various experts in the field, Krishnamoorthy has worked alongside colleagues such as Haiyan Jiang and Tongyao Liu. These partnerships foster innovation and enhance the development of therapeutic methodologies that can benefit patients facing complex medical challenges.

Conclusion

Sriram Krishnamoorthy exemplifies the spirit of innovation within the medical research landscape. His significant patent contributions highlight his commitment to improving patient outcomes and advancing therapies in the realm of factor VIII treatment. As he continues to develop groundbreaking solutions, the medical community eagerly anticipates his future contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…